St. Jude Children’s Research Hospital is the first and only World Health Organization Collaborating Centre for Childhood Cancer. WHO first designated St. Jude its Collaborating Centre for Childhood Cancer in 2018 and redesignated it in 2022.
Support WHO in including childhood cancer in national cancer control plans through tools for prioritization, costing and framework for monitoring and evaluation.
Support WHO in developing tools and platforms for innovation including diffusion in childhood cancer management, research and education.
Support WHO in strengthening childhood cancer control through technical support, training materials and stakeholder engagement.
Following the March 2018 designation as a WHO Collaborating Centre for Childhood Cancer, St. Jude mobilized additional resources to work with WHO and global partners to support progress for children with cancer around the world. This included the launch of the Global Initiative for Childhood Cancer at the United Nations in September 2018, and the ensuing support of the implementation of its CureAll approach to achieve at least a 60% survival rate for children with six of the most common kinds of cancer by 2030. Among more than 180 active Collaborating Centres in the Americas, St. Jude has been recognized as one of nine WHO/PAHO Collaborating Centres specified in the milestone timeline PAHO released for its 120th anniversary in 2022.